We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+8.44%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$580M
AUM Growth
–
Cap. Flow
+$568M
Cap. Flow %
98.01%
Top 10 Hldgs %
82.2%
Holding
25
New
25
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$79.7M
2
QDEL icon
QuidelOrtho
QDEL
+$76.5M
3
ACOR
Acorda Therapeutics
ACOR
+$68.5M
4
THOR
THORATEC CORPORATION
THOR
+$64M
5
OPK icon
Opko Health
OPK
+$40.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 75.11%
2 Consumer Staples 0.41%
3 Financials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QDEL icon
1
QuidelOrtho
QDEL
$1.14B
$83.4M 14.38%
+3,265,457
New +$76.5M
THC icon
2
Tenet Healthcare
THC
$22.6B
$82.1M 14.16%
+1,780,700
New +$79.7M
ACOR
3
DELISTED
Acorda Therapeutics
ACOR
$65.9M 11.36%
+16,637
New +$68.5M
THOR
4
DELISTED
THORATEC CORPORATION
THOR
$59.6M 10.29%
+1,904,949
New +$64M
OPK icon
5
Opko Health
OPK
$1.25B
$41.3M 7.12%
+5,813,742
New +$40.2M
NXTM
6
DELISTED
NxStage Medical Inc.
NXTM
$35.2M 6.06%
+2,462,313
New +$31M
AXDX
7
DELISTED
Accelerate Diagnostics
AXDX
$33.6M 5.8%
+413,976
New +$30.7M
MZOR
8
DELISTED
Mazor Robotics Ltd.
MZOR
$26.9M 4.64%
+1,880,941
New +$23.8M
ONCT
9
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$26.5M 4.58%
+2,871
New +$22.1M
TSRO
10
DELISTED
TESARO, Inc.
TSRO
$22.2M 3.82%
+677,112
New +$20.9M
ARAY icon
11
Accuray
ARAY
$29M
$16.5M 2.84%
+2,868,425
New +$14.5M
GTIV
12
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
$15.8M 2.72%
+1,582,418
New +$16.4M
HNSN
13
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$11.9M 2.06%
+831,562
New +$14.8M
TTHI
14
DELISTED
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
$11.6M 2%
+3,586,497
New +$10.2M
MAKO
15
DELISTED
MAKO SURGICAL CORP COM
MAKO
$11.5M 1.98%
+953,513
New +$10.8M
IRWD icon
16
Ironwood Pharmaceuticals
IRWD
$626M
$11M 1.9%
+1,321,856
New +$16M
PACB icon
17
Pacific Biosciences
PACB
$432M
$4.96M 0.86%
+1,961,688
New +$4.88M
AGEN
18
Agenus
AGEN
$275M
$4.65M 0.8%
+62,446
New +$5.06M
WBMD
19
DELISTED
WebMD Health Corp.
WBMD
$4.32M 0.75%
+147,112
New +$3.93M
VRML
20
DELISTED
Vermillion, Inc.
VRML
$4.09M 0.71%
+2,799,980
New +$6.03M
BIIB icon
21
Biogen
BIIB
$30.4B
$2.5M 0.43%
+11,603
New +$2.48M
YTEN
22
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$2.35M 0.41%
+29
New +$2.8M
AVEO
23
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1.44M 0.25%
+57,500
New +$2.46M
MNKD icon
24
MannKind Corp
MNKD
$1.21B
$356K 0.06%
+10,948
New +$293K
LTS
25
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$275K 0.05%
+166,849
New +$260K

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Oracle Investment Management, which disclosed 25 positions worth $580M. Its ten largest holdings account for 82% of the portfolio.

Its largest position is Tenet Healthcare: 1,780,700 shares worth $82.1M.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets, followed by Consumer Staples and Financials.

  • Oracle Investment Management's largest Q2 2013 buy was Tenet Healthcare: 1,780,700 shares worth $82.1M.
  • Oracle Investment Management's ten largest holdings make up 82% of its $580M portfolio in Q2 2013.
  • Oracle Investment Management disclosed 25 positions in Q2 2013, its first 13F filing on record.

Based on Oracle Investment Management's 13F filing for Q2 2013, filed 14 Aug 2013.